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With the increase in antibacterial resistance, the need for new antibiotics is increasing. Antibiotics
work by interfering with a vital function of the bacteria thus killing the bacteria. One way to
interfere with a vital cell function is to inhibit the bacterial cell wall formation. The dapE-encoded
N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) enzymes catalyze the hydrolysis of N-
succinyl-L,L-diaminopimelic acid (L,L-SDAP) to succinic acid and L,L-diaminopimelate (DAP).
Then DAP is converted to m-DAP and ultimately to lysine (Scheme 1). Lysine and mDAP are
crucial in bacteria cell wall synthesis. Lysine is an essential amino acid for humans meaning that it
has to be ingested and mammals do not make lysine themselves. Since there is no similar pathway
in the human body, inhibiting this enzyme would be selectively toxic to bacteria. This enzyme is
present in 98% of Gram-negative and in all Gram-positive bacteria. This shows that DapE could
serve as a broad-spectrum antibiotic especially when targeting ESKAPE (Enterococcus faecium,
Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas
aeruginosa, and Enterobacter species) pathogens. Studies have shown that when the gene encoding
the DapE enzyme is deleted the bacteria cannot survive even in a lysine supplemented media.
Scheme 1. DapE catalyzed
reaction
The Becker research lab has obtained five lead molecules through high-throughput screening
(HiTS), one being the tetrazole-based analog (Figure 1). Synthesis of the bioisosteric analogs of the
tetrazole hit and obtaining their inhibitory potencies using our ninhydrin-based assay will be the
focus of this project.
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Introduction
Figure 1. Tetrazole-based lead 
molecule.
Synthesis of Pyrazole-based Analog
Scheme 2. 
Synthesis of 
Pyrazole Analog
Future Work
Figure 2:  (A) Open 
conformation of apo-HiDapE
enzyme, (B) Closed 
conformation of HiDapE
products-bound structure.
Figure 3. Interaction (A) Tetrazole original hit and 
(B) Pyrazole analog with the DapE active site.
DapE is a homodimeric metalloenzyme
and the active sites contain two zinc ions
(Figure 2). DapE has two conformations:
open and closed. The open to closed
conformation is induced by the binding of
the substrate. Docking images of tetrazole
original lead molecule and the hit-derived
pyrazole analog show the interactions
with different residues in the DapE active
site which is useful to find the
pharmacophore of our lead molecule
(Figure 3).
The Buchwald-Hartwig reactions produce many biproducts, so I would like to optimize these
conditions and purification technique to isolate the desired product. New SNAR conditions will
also be employed in the pyrazole analog synthesis. The inhibitor molecules will be tested against
DapE using our ninhydrin assay to determine the IC50 values. The final goal of this project is to
synthesize a nanomolar potent inhibitor of DapE driven by SAR and Molecular docking.
Due to the increase in antibacterial resistance, there is an urgent need for new and novel antibacterial drugs. The target enzyme for this project is the dapE-encoded bacterial enzyme N-succinyl-L,L-diaminopimelic acid
desuccinylase (DapE). DapE is a key enzyme in the synthesis of bacterial cellular walls via the lysine biosynthetic pathway. DapE inhibitors should selectively target bacterial DapE which will be lethal to bacteria with no
mechanism-based toxicity in humans due to the absence of the lysine biosynthetic pathway in mammals. Thus DapE enzyme is an ideal target for novel antibiotics. The lead molecules identified by the Becker lab via a
High-Throughput screen include the tetrazole, (2-[(1-phenyl-1H-tetrazol-5-yl)sulfanyl]-N-(1,3-thiazol-2-yl)propanamide). Synthesis of new analogs of this lead molecule will be described.
Background
Scheme 3.  Buchwald-Hartwig Reaction of 5-OTf pyrazol
analog with L-Phenylalanine
Scheme 4.  Buchwald-Hartwig Reaction of 5-OTf pyrazol
analog with L-Phenylalanine methyl ester 
Scheme 3 shows one of the
Buchwald-Hartwig reactions with
L-Phenylalanine as a carboxylic
acid while scheme 4 shows L-
Phenylalanine methyl ester. The
methyl ester analog in scheme 3
has produced many biproducts due
to the instability of the L-
Phenylalanine methyl ester in the
basic medium. Currently working
on the best purification process to
isolate the desired product.
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The first step in scheme 2
has been successfully
completed and the product
has been isolated with a
95.5% yield. The second
step of this scheme is
elaborated on below.
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